Sponsor Pipeline

Boehringer Ingelheim Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
90
Active Trials
45
Recruiting
22
Phase 3
10
Disease Areas
54
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-12 NCT06531824
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With…
Trial sites expanded: 459 -> 475 locations
2026-06-12 NCT06632457
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver…
Trial sites expanded: 444 -> 447 locations
2026-06-11 NCT07409181
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus…
Trial sites expanded: 134 -> 139 locations
2026-06-11 NCT07220083
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition…
Trial sites expanded: 271 -> 277 locations
2026-06-11 NCT07325526
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver…
date change Primary completion pushed: 2027-03-29 -> 2027-06-29
2026-06-11 NCT07325526
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver…
date change Completion pushed: 2027-03-29 -> 2027-07-02
2026-06-11 NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin…
Trial sites expanded: 1152 -> 1155 locations
2026-06-11 NCT07036523
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With…
date change Completion moved earlier: 2027-11-01 -> 2027-06-22
2026-06-11 NCT07306559
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With…
date change Primary completion pushed: 2029-04-21 -> 2029-09-07
2026-06-10 NCT07361302
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given…
Trial sites expanded: 228 -> 242 locations
2026-06-10 NCT07540988
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing…
Trial sites expanded: 100 -> 126 locations
2026-06-10 NCT05846516
A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With…
Trial sites reduced: 24 -> 20 locations
2026-06-10 NCT05846516
A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With…
date change Primary completion moved earlier: 2027-06-27 -> 2027-03-08
2026-06-10 NCT05846516
A Study to Test KISIMA-02 Vaccine-based Immunotherapy and Ezabenlimab in People With…
date change Completion moved earlier: 2027-06-27 -> 2027-03-08
2026-06-10 NCT07023354
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver…
date change Primary completion pushed: 2026-08-01 -> 2026-09-17
2026-06-10 NCT07023354
A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver…
date change Completion pushed: 2026-08-01 -> 2026-09-17
2026-06-10 NCT05916313
A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a…
Enrollment increased: 18 -> 20 participants
2026-06-10 NCT06132113
DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to…
overall status: "Recruiting" → "Active Not Recruiting"
2026-06-05 NCT07395258
A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1…
Recruitment suspended
2026-06-05 NCT07395258
A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1…
critical why stopped: null → "Temporary enrolment hold as a precautionary measure following a safety event in a related trial"
Showing 20 of 54 changes detected in the last 30 days.
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-26 NCT07607678 A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are… Phase 1 Recruiting
Active Trials by Phase
Phase 4
1
Phase 3
22
Phase 2
17
Phase 1/2
3
Phase 1
36
Not specified
11
Active Trials — top 25 of 90
NCT IDTitleConditionStatus
Phase 4
NCT06013969 A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP)… Generalized Pustular Psoriasis Active, Not Recruiting
Phase 3
NCT07195695 Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely… Non-small Cell Lung Cancer Recruiting
NCT06424288 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With… Heart Failure Recruiting
NCT07201922 A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People… Familial Pulmonary Fibrosis Recruiting
NCT07361302 A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given… Acute Ischemic Stroke Recruiting
NCT07472517 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare… Small Cell Lung Cancer (SCLC) Recruiting
NCT06624670 A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma… Pyoderma Gangrenosum Recruiting
NCT06806592 A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic… Interstitial Lung Diseases Recruiting
NCT06872892 The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With… Bronchiectasis Recruiting
NCT06935370 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps… Heart Failure Recruiting
NCT07064473 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… Diabetes Mellitus, Type 2 Recruiting
NCT07220083 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition… Focal Segmental Glomerulosclerosis Recruiting
NCT06238622 A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary… Idiopathic Pulmonary Fibrosis Recruiting
NCT06531824 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With… Kidney Disease, Chronic Recruiting
NCT06632444 LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called… Metabolic Dysfunction Associated Steatohepatitis (MASH) Recruiting
NCT06632457 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver… Metabolic Dysfunction Associated Steatohepatitis Recruiting
NCT07107945 A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and… Chronic Kidney Disease Recruiting
NCT07366034 A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps… Fibrosing Interstitial Lung Disease Not Yet Recruiting
NCT06151574 Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With… Lung Cancer, Non-squamous, Non-small Cell Active, Not Recruiting
NCT07540988 FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing… Interstitial Lung Diseases Not Yet Recruiting
NCT07544654 DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to… Extrapulmonary Neuroendocrine Cancer Not Yet Recruiting
NCT07497087 A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis Systemic Sclerosis Not Yet Recruiting
NCT06077864 A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People… Obesity Active, Not Recruiting
Phase 2
NCT05882058 DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small… Small Cell Lung Carcinoma Recruiting
NCT06241560 A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone… Idiopathic Pulmonary Fibrosis Recruiting
View all 90 active Boehringer Ingelheim trials with filters →
Disease Areas
Get alerts when Boehringer Ingelheim's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free